摘要
目的研究并探讨黛力新联合西比灵治疗偏头痛患者的临床治疗效果。方法以我院共收治的120例偏头痛患者为研究对象,并运用随机分组的方式将所有的患者分为两组,即治疗组和对照组各60例,对照组的患者运用传统的治疗方式进行治疗,而治疗组的患者则运用黛力新联合西比灵的方式来进行治疗,对比两组患者的临床治疗效果。结果治疗组患者治疗后,其偏头痛的发作次数为(0.88±0.25),持续时间为(1.75±0.04),而对照组患者治疗后,其偏头痛的发作次数为(0.98±0.38),持续的时间为(1.72±0.86),对比P<0.05,具有统计学意义。此外,治疗组患者在治疗之后,出现不良反应的患者为2例,而对照组出现不良反应的患者为5例,对比P<0.05,具有显著的统计学意义。结论对于偏头痛的患者而言,运用黛力新联合西比灵的方式来进行治疗不仅非常的安全和可靠,且具有相当显著的临床治疗效果,值得在现代的临床中进行大力的推广与应用。
Objective To study and to explore deanxit joint sibelium treatment in patients with migraine of clinical therapeutic effect. Methods A total of 120 cases of our were migraine patients as the research object, and using the random grouping ways of putting all of the patients were divided into two groups, namely the treatment group and the control group of 60 cases and control of the patients with traditional treatments for treatment, and the treatment group of patients are using deanxit joint sibelium way to treatment, compared to two sets of patients clinical therapeutic effect. Results Ttreatment group patients after treatment, the number of migraine headache was （0.88±0.25）, duration was （1.75±0.04）, and control group patients after treatment, the number of migraine headache was （0.98±0.38）, continuous time was （1.72±0.86）, compared to P〈0.05, with statistical significance. In addition, the treatment group patients after treatment, appear adverse reaction of the patients for 2 cases, and control group appeared adverse reaction of the patients for 5 cases, contrast P〈0.05, has the remarkable statistical significance. Conclusion For patients with migraine in use deanxit joint sibelium way to treatment not only very safe and reliable, and has significant clinical therapeutic effect, it is worth in the modem clinical in strong popularization and application.
出处
《中国医药指南》
2013年第8期44-45,共2页
Guide of China Medicine
